ROBERT BURNSTEIN: Open Payments
NPI 1295827350 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,124 in 116 payments from 19 companies in 2025. Trend: 2023 $1,769 · 2024 $1,224 · 2025 $2,124
Food & beverage: $2,124
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $352 |
| Vanda Pharmaceuticals Inc. | 13 | $250 |
| Validus Pharmaceuticals LLC | 16 | $248 |
| Axsome Therapeutics, Inc. | 13 | $191 |
| Neurocrine BioSciences, Inc. | 13 | $189 |
| Alkermes, Inc. | 10 | $184 |
| Lundbeck LLC | 9 | $153 |
| ABBVIE INC. | 9 | $141 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
Products named: COBENFY, FANAPT, EQUETRO, REXULTI, INGREZZA, Auvelity, LYBALVI, VRAYLAR.
Industry payments across MI — which companies pay providers there.
